Capital Flow Monitor · Sponsors · CIK 1952448

Liberation Bioindustries, Inc.

14 Wall Street, NEW YORK, NY, 10005 · 917-539-8620

Other Technology · Corporation· inc. DELAWARE true 2022

Fit score

—

Offering

$101.7M

Sold

$60.2M

% sold

59.2%

Investors

7

Min investment

$0

Exemption

506(b)

Filing history

FiledFormRuleOfferingSold% soldInvestors
2025-12-10 D ·current 506(b) $101.7M $60.2M 59.2% 7 EDGAR ↗

Related persons

Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.

  • Mark Warner — Executive Officer / Director, New York, NY
  • James Mellon — Director, New York, NY
    1 other raise
  • Babar Khan — Director, New York, NY
  • Steven Finn — Director, New York, NY
    1 other raise
  • Philip Boigner — Director, New York, NY
  • Etan Bendheim — Executive Officer, New York, NY

Placement agents

  • No sales compensation reported — direct raise.

Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.